Furthermore, multiple candidate KRAS-interacting proteins are studied for their effects on lung cancer growth in a genetically engineered mouse model using multiplex somatic CRISPR/Cas9 screenig combined with Tuba-seq. The gene discussed is KRAS; the disease is lung carcinoma.